Skip to content

Innoviva, Inc. INVA Intangibles (Net)

Intangibles (Net) at other companies

Insmed logo
InsmedINSM
$95.57M+66.5%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$217.34M-15.9%
Organon logo
OrganonOGN
$1.1B-22.4%
LQD
Liquidia CorporationLQDA
$2.89M-7.1%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$467.16M-10.6%
Alkermes logo
AlkermesALKS

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s intangibles (net)?
Innoviva, Inc. (INVA) reported intangibles (net) of $175.6M in Q1 2026.
How has Innoviva, Inc.'s intangibles (net) changed year-over-year?
Innoviva, Inc.'s intangibles (net) decreased by 13.1% year-over-year, from $201.96M to $175.6M.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.